HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gianina Ravenscroft Selected Research

Multiple pterygium syndrome

6/2017Lethal multiple pterygium syndrome: A severe phenotype associated with a novel mutation in the nebulin gene.
2/2013Whole exome sequencing in foetal akinesia expands the genotype-phenotype spectrum of GBE1 glycogen storage disease mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gianina Ravenscroft Research Topics

Disease

10Muscular Diseases (Myopathy)
11/2022 - 02/2013
7Nemaline Myopathies (Nemaline Myopathy)
01/2020 - 12/2010
3Arthrogryposis
01/2022 - 02/2013
2type 1 Pena Shokeir syndrome
12/2018 - 06/2017
2Multiple pterygium syndrome
06/2017 - 02/2013
2Muscle Weakness
11/2015 - 01/2012
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
08/2014 - 09/2010
1Muscular Atrophy (Muscle Atrophy)
11/2022
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2022
1Peripheral Nervous System Diseases (PNS Diseases)
01/2022
1Fasciculation (Fasciculations)
10/2020
1Glycogen Storage Disease Type V (McArdle's Disease)
01/2020
1Disease Progression
01/2020
1Rare Diseases (Rare Disease)
01/2018
1Neuromuscular Diseases (Neuromuscular Disease)
11/2015
1Hypokinesia (Bradykinesia)
11/2015
1Congenital Structural Myopathies (Centronuclear Myopathy)
08/2014
1familial dilated cardiomyopathy
07/2013
1Contracture
02/2013
1Myofibrillar Myopathy
06/2011
1Pathological Protein Aggregation
06/2011
1Distal Myopathies (Distal Muscular Dystrophy)
06/2011
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
09/2010
1Cardiomegaly (Heart Hypertrophy)
04/2010
1Hypertrophy
04/2010
1Ophthalmoplegia (External Ophthalmoplegia)
12/2008

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2010
2Creatine Kinase (Creatine Phosphokinase)IBA
11/2022 - 10/2020
2nebulinIBA
01/2020 - 06/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 11/2015
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2017 - 11/2015
2Myosins (Myosin)IBA
11/2015 - 01/2012
2CalciumIBA
02/2013 - 04/2010
2Actins (F Actin)IBA
09/2010 - 12/2008
1Neuregulin-1 (Neuregulin 1)IBA
01/2022
1LaminsIBA
01/2022
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2022
1Nonsense Codon (Nonsense Mutation)IBA
01/2020
1EnzymesIBA
01/2020
1GlycogenIBA
01/2020
1Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA
01/2020
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
12/2018
1Cofilin 2IBA
09/2014
1LipidsIBA
08/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
08/2014
1myotubularinIBA
08/2014
1Protein Isoforms (Isoforms)IBA
11/2013
1Troponin IIBA
07/2013
1TropomyosinIBA
02/2013
11,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA
02/2013
1FilaminsIBA
06/2011
1Mitochondrial Proteins (Mitochondrial Protein)IBA
04/2010

Therapy/Procedure

4Therapeutics
01/2020 - 11/2013
1Continuous Positive Airway Pressure
11/2022
1Noninvasive Ventilation
01/2019